Menu Search
Equities

Coloplast A/S

CLPBF:PKL

Coloplast A/S

Actions
  • Price (USD)120.05
  • Today's Change-4.66 / -3.73%
  • Shares traded132.00
  • 1 Year change+13.79%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 16:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in DKK

The one analyst offering a 12 month price target expects Coloplast A/S share price to fall to 14.44 in the next year from the last price of 120.05.
High-88.0%14.44
Med-88.0%14.44
Low-88.0%14.44

Dividends in DKK

Historical dividend information is not available for Coloplast A/S.
Div growth (TTM)4.76%
More ▼

Earnings history & estimates in DKK

On Nov 05, 2024, Coloplast A/S reported 4th quarter 2024 earnings of 5.84 per share. This result was in line with the consensus of the 2 analysts following the company and exceeded last year's 4th quarter results by 6.76%.
The next earnings announcement is expected on Feb 07, 2025.
Average growth rate+1.67%
Coloplast A/S reported annual 2024 earnings of 22.34 per share on Nov 05, 2024.
Average growth rate+3.45%
More ▼

Revenue history & estimates in DKK

-32768 had 4th quarter 2024 revenues of 6.95bn. This bettered the 6.91bn consensus of the 5 analysts covering the company. This was 13.89% above the prior year's 4th quarter results.
Average growth rate+2.83%
-32768 had revenues for the full year 2024 of 27.03bn. This was 10.33% above the prior year's results.
Average growth rate+9.96%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.